TR199801630T1 - Eczasal bir maddenin kristal modifikasyonu. - Google Patents

Eczasal bir maddenin kristal modifikasyonu.

Info

Publication number
TR199801630T1
TR199801630T1 TR1998/01630T TR9801630T TR199801630T1 TR 199801630 T1 TR199801630 T1 TR 199801630T1 TR 1998/01630 T TR1998/01630 T TR 1998/01630T TR 9801630 T TR9801630 T TR 9801630T TR 199801630 T1 TR199801630 T1 TR 199801630T1
Authority
TR
Turkey
Prior art keywords
crystal modification
pharmaceutical substance
modification
formula
crystal
Prior art date
Application number
TR1998/01630T
Other languages
English (en)
Turkish (tr)
Inventor
Portmann Robert
Christoph Hofmeier Urs
Scherrer Walter
Szelagiewicz Martin
Burkhard Andreas
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4209650&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR199801630(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TR199801630T1 publication Critical patent/TR199801630T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
TR1998/01630T 1997-06-10 1998-06-08 Eczasal bir maddenin kristal modifikasyonu. TR199801630T1 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH140497 1997-06-10

Publications (1)

Publication Number Publication Date
TR199801630T1 true TR199801630T1 (xx) 1999-06-21

Family

ID=4209650

Family Applications (2)

Application Number Title Priority Date Filing Date
TR1998/01630T TR199801630T1 (xx) 1997-06-10 1998-06-08 Eczasal bir maddenin kristal modifikasyonu.
TR1998/01631T TR199801631T1 (xx) 1997-06-10 1998-06-08 Eczasal bir maddenin kristal modifikasyonu.

Family Applications After (1)

Application Number Title Priority Date Filing Date
TR1998/01631T TR199801631T1 (xx) 1997-06-10 1998-06-08 Eczasal bir maddenin kristal modifikasyonu.

Country Status (36)

Country Link
US (6) US6740669B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (2) EP0994864B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (2) JP3672575B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (2) KR100409168B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (3) CN1132820C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (4) AR012945A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (2) ATE232852T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (2) AU725528B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (2) BR9804946A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (3) CA2256015C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CO (2) CO4940448A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CY (1) CY2007014I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CZ (2) CZ292481B6 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (3) DE69813560T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (2) DK0994864T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (2) ES2192779T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR07C0037I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (2) HU226107B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ID (2) ID27660A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (2) IL125732A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU91345I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY (2) MY125854A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL300284I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (2) NO329314B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (2) NZ331370A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PE (2) PE79799A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (2) PL191943B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT994864E (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RU (2) RU2194041C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SI (2) SI0994863T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SK (2) SK283685B6 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TR (2) TR199801630T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (2) TW403740B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
UY (1) UY25844A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (2) WO1998056772A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (2) ZA984967B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW403740B (en) 1997-06-10 2000-09-01 Novartis Ag Novel crystal modifications of the compound 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide
WO2003101991A1 (en) * 2002-05-31 2003-12-11 Schering Corporation Xanthine phosphodiesterase v inhibitor polymorphs
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds
US7875284B2 (en) * 2006-03-10 2011-01-25 Cook Incorporated Methods of manufacturing and modifying taxane coatings for implantable medical devices
US20090069390A1 (en) * 2007-09-12 2009-03-12 Protia, Llc Deuterium-enriched rufinamide
US8183269B2 (en) 2008-10-13 2012-05-22 Cipla Limited Process for the preparation of rufinamide
CN101768124B (zh) * 2008-12-30 2012-01-04 北京本草天源药物研究院 一种药物晶体及其制备方法和用途
IT1395736B1 (it) * 2009-08-04 2012-10-19 Dipharma Francis Srl Forme cristalline di rufinamide
AU2010290049B2 (en) * 2009-09-04 2013-09-19 Tactical Therapeutics, Inc Novel compositions and processes for preparing 5-amino or substituted amino 1,2,3-triazoles and triazole orotate formulations
EP2465853A1 (en) * 2010-12-14 2012-06-20 Laboratorios Lesvi, S.L. Polymorph of rufinamide and process for obtaining it
JP2013525413A (ja) * 2010-04-30 2013-06-20 ラボラトリオス レスヴィ，エス．エル． ルフィナマイド中間体の改良された製造方法
ITMI20110718A1 (it) 2011-04-29 2012-10-30 Dipharma Francis Srl Procedimento per la purificazione di rufinamide
US10206874B2 (en) 2012-07-20 2019-02-19 Hetero Research Foundation Rufinamide solid dispersion
WO2021099481A1 (en) 2019-11-20 2021-05-27 Medichem, S.A. Solid composition containing rufinamide

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992378A (en) 1973-12-26 1976-11-16 Eli Lilly And Company Fluoralkyl quinoxadinediones
US4156734A (en) 1976-02-13 1979-05-29 Merck & Co., Inc. Antihypertensive compositions containing an aryl-substituted alanine azo and an arylhydrazino-propionic acid
GB1511195A (en) 1976-10-18 1978-05-17 Ici America Inc Triazole derivatives
US4536518A (en) 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US4346097A (en) * 1980-09-30 1982-08-24 Warner-Lambert Company Method for treating convulsions with pyrazole-4-carboxamide derivatives
US4789680A (en) * 1982-12-23 1988-12-06 Ciba-Geigy Corporation Aralkyltriazole compounds
FI834666A7 (fi) 1982-12-23 1984-06-24 Ciba Geigy Ag Foerfarande foer framstaellning av nya aralkyltriazolfoereningar.
US4511572A (en) * 1983-03-18 1985-04-16 The University Of Kentucky Research Foundation Triazoline anticonvulsant drugs
FI93544C (fi) * 1985-04-18 1995-04-25 Ciba Geigy Ag Menetelmä fluorattujen, antikonvulsiivisesti vaikuttavien 1-bentsyyli-1H-1,2,3-triatsoliyhdisteiden valmistamiseksi
CA2002864C (en) 1988-11-29 1999-11-16 Eddy J. E. Freyne (1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives
JPH02214504A (ja) 1989-02-15 1990-08-27 Nissan Chem Ind Ltd 光学活性キノキサリン化合物の晶析法
JPH04506967A (ja) 1989-07-27 1992-12-03 ジー．ディー．サール　アンド　カンパニー 高血圧症治療用腎選択性生成物
IL96507A0 (en) 1989-12-08 1991-08-16 Merck & Co Inc Nitrogen-containing spirocycles and pharmaceutical compositions containing them
AU656154B2 (en) 1990-11-06 1995-01-27 Astellas Pharma Inc. Fused pyrazine derivative
JP2753911B2 (ja) 1991-12-06 1998-05-20 キッセイ薬品工業株式会社 Ｎ−ｔｅｒｔ−ブチル−１−メチル−３，３−ジフェニルプロピルアミン塩酸塩の結晶多形およびその製造方法
DE4217952A1 (de) 1992-05-30 1993-12-02 Basf Ag Chinoxalin-2,3(1H,4H)-dione
US5248699A (en) 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
US5631373A (en) 1993-11-05 1997-05-20 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones
GB9418443D0 (en) 1994-09-13 1994-11-02 Pfizer Ltd Therapeutic agents
GB9419318D0 (en) 1994-09-24 1994-11-09 Pfizer Ltd Therapeutic agents
DE69609314T2 (de) 1995-02-22 2001-06-13 Aventis Pharma Ltd., Tokio/Tokyo Amorph piretanide, polymorphe davon, verfahren zur dessen herstellung und ihre verwendung
SI0918758T1 (en) * 1996-07-11 2002-10-31 Novartis Ag Process for preparing 1-substituted 4-cyano-1,2,3-triazoles
TW403740B (en) * 1997-06-10 2000-09-01 Novartis Ag Novel crystal modifications of the compound 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide

Also Published As

Publication number Publication date
US20010037029A1 (en) 2001-11-01
CY2007014I1 (el) 2009-11-04
WO1998056772A1 (en) 1998-12-17
IL125732A (en) 2002-12-01
CN1259127A (zh) 2000-07-05
PL191943B1 (pl) 2006-07-31
JP3672574B2 (ja) 2005-07-20
US20040167186A1 (en) 2004-08-26
CO4940448A1 (es) 2000-07-24
CY2007014I2 (el) 2009-11-04
ID27660A (id) 2001-04-19
ZA984966B (en) 1999-01-11
SI0994864T1 (en) 2003-10-31
CN1132820C (zh) 2003-12-31
PL330798A1 (en) 1999-06-07
US6740669B1 (en) 2004-05-25
NO983667L (no) 1998-12-17
KR100409168B1 (ko) 2004-01-31
ZA984967B (en) 1999-01-11
RU2194041C2 (ru) 2002-12-10
ID21014A (id) 1999-04-08
LU91345I2 (fr) 2007-09-04
KR19990087836A (ko) 1999-12-27
MY120156A (en) 2005-09-30
DE69813560D1 (de) 2003-05-22
CN1159300C (zh) 2004-07-28
AU8437198A (en) 1998-12-30
DE122007000051I2 (de) 2009-02-19
MY125854A (en) 2006-08-30
CZ253398A3 (cs) 1999-04-14
PE80999A1 (es) 1999-09-06
DE122007000051I1 (de) 2007-11-08
US20100310655A1 (en) 2010-12-09
DK0994864T3 (da) 2003-07-21
US20030125568A1 (en) 2003-07-03
ATE237599T1 (de) 2003-05-15
US20060116520A1 (en) 2006-06-01
ES2192779T3 (es) 2003-10-16
HU226107B1 (en) 2008-04-28
RU2198167C2 (ru) 2003-02-10
TW526195B (en) 2003-04-01
DE69811500T2 (de) 2004-04-01
DE69811500D1 (de) 2003-03-27
EP0994864B1 (en) 2003-04-16
HK1028242A1 (en) 2001-02-09
CZ292481B6 (cs) 2003-09-17
JP3672575B2 (ja) 2005-07-20
HU225153B1 (en) 2006-07-28
DK0994863T3 (da) 2003-05-26
NZ331370A (en) 2000-08-25
ES2197485T3 (es) 2004-01-01
KR100425656B1 (ko) 2004-05-17
NO329314B1 (no) 2010-09-27
CZ292260B6 (cs) 2003-08-13
US7750028B2 (en) 2010-07-06
LU91345I9 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2018-12-31
AR012945A1 (es) 2000-11-22
NO983666L (no) 1998-12-17
HUP0002113A3 (en) 2002-09-30
JP2000516259A (ja) 2000-12-05
HUP0000798A2 (hu) 2000-10-30
AU8437298A (en) 1998-12-30
SK109498A3 (en) 1998-12-02
HK1028031A1 (en) 2001-02-02
ATE232852T1 (de) 2003-03-15
PT994864E (pt) 2003-07-31
TW403740B (en) 2000-09-01
EP0994864A1 (en) 2000-04-26
PL330764A1 (en) 1999-05-24
NZ331371A (en) 2000-08-25
CN1572789A (zh) 2005-02-02
NL300284I2 (nl) 2007-11-01
KR19990087835A (ko) 1999-12-27
CA2614926A1 (en) 1998-12-17
US8076362B2 (en) 2011-12-13
AU725517B2 (en) 2000-10-12
CA2256013A1 (en) 1998-12-17
UY25844A1 (es) 2001-08-27
NO329315B1 (no) 2010-09-27
AR061004A2 (es) 2008-07-30
HUP0000798A3 (en) 2000-10-30
IL125732A0 (en) 1999-04-11
BR9804946A (pt) 1999-08-24
US6455556B2 (en) 2002-09-24
HUP0002113A2 (hu) 2001-02-28
EP0994863B1 (en) 2003-02-19
IL125733A0 (en) 1999-04-11
SK283685B6 (sk) 2003-12-02
BR9804947A (pt) 1999-08-24
AR012946A1 (es) 2000-11-22
CZ253498A3 (cs) 1999-04-14
SK283734B6 (sk) 2003-12-02
WO1998056773A1 (en) 1998-12-17
NO983666D0 (no) 1998-08-11
FR07C0037I1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2007-08-17
CN1298708C (zh) 2007-02-07
CA2256015A1 (en) 1998-12-17
PE79799A1 (es) 1999-09-03
AU725528B2 (en) 2000-10-12
IL125733A (en) 2002-12-01
SK109398A3 (en) 1998-12-02
NL300284I1 (nl) 2007-10-01
NO983667D0 (no) 1998-08-11
TR199801631T1 (xx) 1999-06-21
CA2614926C (en) 2010-02-09
AR061005A2 (es) 2008-07-30
CA2256013C (en) 2007-10-16
HK1028241A1 (en) 2001-02-09
CN1217716A (zh) 1999-05-26
FR07C0037I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2008-05-16
SI0994863T1 (en) 2003-08-31
CO4940452A1 (es) 2000-07-24
DE69813560T2 (de) 2004-02-05
PL192114B1 (pl) 2006-08-31
EP0994863A1 (en) 2000-04-26
JP2000516258A (ja) 2000-12-05
CA2256015C (en) 2008-06-03

Similar Documents

Publication Publication Date Title
TR199801630T1 (xx) Eczasal bir maddenin kristal modifikasyonu.
NO963133D0 (no) 12,13-isotaksolanaloger, antineoplastisk anvendelse og farmasöytiske preparater inneholdende disse
ATE238790T1 (de) Verwendung von pramipexole als neuroschutzmittel
TR199903332T2 (xx) Eletriptan hemis�lfat ve kafein i�eren farmas�tikal bile�ikler.
TR200000148T2 (tr) 1-(4-Karbazoliloksi)-3-(2-metoksifenoksi) etilamino)-2-propanol' ün modifikasyonu, gerekli proses ve farmasötik bileşimler.
IT1293778B1 (it) 1,4,7,10-tetraazabiciclo(8.2.2.)tetradecan-2 one, sua preparazione e suo uso per la preparazione di tetraazamacrocicli
ATE268750T1 (de) Proteintyrosinphosphatase inhibitoren
FI955118A0 (fi) Herbisidiset substituoidut 1-fenyyli- tai 1-pyridinyyli-bentsotriatsolit
NO971997D0 (no) Bruk av immunmodulerende midler
BR9509741A (pt) Composto e uso de composto
NO980717L (no) Uracil reduktase inaktivatorer
ATE155130T1 (de) Fluorverbindungen als aromatase-inhibitoren
NO922811D0 (no) Beleggmateriale, samt fremgangsmaate ved fremstilling og anvendelse derav
DE59108566D1 (de) Heteroarylmethylbenzole-Aromatasehemmer
SV1998000088A (es) Compuestos farmaceuticos
TH144580A (th) รูปแบบโครงสร้างผลึกดัดแปลงของ 1-(2,6-ไดฟลูออโรเบนซิล)-1h-1,2,3-ไตรอาโซล-4-คาร์บอกซาไมด์
ES2118221T3 (es) Derivados de carbamato y su uso en medicina.
PT984948E (pt) Sulfoniloxadiazolonas
TH9801002100B (th) รูปแบบโครงสร้างผลึกดัดแปลงของ 1-(2,6-ไดฟลูออโรเบนซิล)-1h-1,2,3-ไตรอาโซล-4-คาร์บอกซาไมด์
TR200103169T2 (tr) 1,5-Benzodiazepin türevleri
NO880973L (no) 1-(1-aryl-2-hydroksyetyl)-imidazoler og salter derav samtfremgangsmaater for fremstilling av forbindelsene.
TH13660A (th) อนุพันธ์ของไทรแอโซล และอิมิแดโซลชนิดใหม่ซึ่งมีฤทธิ์ฆ่าเชื้อรา
TH144580B (th) การดัดเเปลงผลึกของสารออกฤทธิ์ทางเภสัชกรรม
BR9802498A (pt) Estojo para guardar e tansportar materiais e medicamentos de primeiro socorros
MX9801273A (es) Carbamoilcarboxamidas.